输液参数,安全性和手动注射皮下免疫球蛋白20% (Ig20Gly) 的实用指南

Dorothea Grosse-Kreul1, Crystal Allen2,3,4, Chrystyna Kalicinsky5

  • 1School of Immunology and Microbial Sciences, Department of Immunological Medicine and Allergy, King's College Hospital NHS Foundation Trust, King's Health Partners, London, UK. d.grosse-kreul@nhs.net.

概括

手动注射免疫球蛋白 (Ig20Gly) 为原发性免疫缺陷疾病 (PID) 提供了一种更快,更耐受的替代方案. 与输液相比,这种方法提供了可比的患者满意度和显著的医疗成本节省.